Showing 1 - 12 results of 12 for search 'Dong-Yu Wang', query time: 0.04s Refine Results
  1. 1
    CDK4/6 inhibitors and the pRB-E2F1 axis suppress PVR and PD-L1 expression in triple-negative breast cancer

    CDK4/6 inhibitors and the pRB-E2F1 axis suppress PVR and PD-L1 expression in triple-negative breast cancer by Mariusz Shrestha, Dong-Yu Wang, Yaacov Ben-David, Eldad Zacksenhaus

    Published 2023-05-01
    Get full text
    Article
  2. 2
    A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling

    A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling by Dong-Yu Wang, Deena M. A. Gendoo, Yaacov Ben-David, James R. Woodgett, Eldad Zacksenhaus

    Published 2019-01-01
    Get full text
    Article
  3. 3
    Stille coupling via C–N bond cleavage

    Stille coupling via C–N bond cleavage by Dong-Yu Wang, Masatoshi Kawahata, Ze-Kun Yang, Kazunori Miyamoto, Shinsuke Komagawa, Kentaro Yamaguchi, Chao Wang, Masanobu Uchiyama

    Published 2016-09-01
    Get full text
    Article
  4. 4
    Maternal Thyroid-Stimulating Hormone Level and Thyroid Peroxidase Antibody Status in the First and Second Trimester of Pregnancy and Their Relationship with the Risk of Gestational Diabetes Mellitus

    Maternal Thyroid-Stimulating Hormone Level and Thyroid Peroxidase Antibody Status in the First and Second Trimester of Pregnancy and Their Relationship with the Risk of Gestational... by Song-Qing Deng, Hai-Tian Chen, Dong-Yu Wang, Bin Liu, Han-Qing Chen, Zi-Lian Wang, Yang Pan, Dan-Dan Shi

    Published 2019-10-01
    Get full text
    Article
  5. 5
    Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance

    Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance by Dong-Yu Wang, Ya-Nan Wu, Jun-Qi Huang, Wei Wang, Meng Xu, Jin-Peng Jia, Gang Han, Bei-Bei Mao, Wen-Zhi Bi

    Published 2016-05-01
    Get full text
    Article
  6. 6
    Non-transition Metal-Mediated Diverse Aryl–Heteroatom Bond Formation of Arylammonium Salts

    Non-transition Metal-Mediated Diverse Aryl–Heteroatom Bond Formation of Arylammonium Salts by Dong-Yu Wang, Xin Wen, Chao-Dong Xiong, Jian-Nan Zhao, Chun-Yong Ding, Qian Meng, Hu Zhou, Chao Wang, Masanobu Uchiyama, Xiao-Jie Lu, Ao Zhang

    Published 2019-05-01
    Get full text
    Article
  7. 7
    CDC25 as a common therapeutic target for triple-negative breast cancer - the challenges ahead

    CDC25 as a common therapeutic target for triple-negative breast cancer - the challenges ahead by Eldad Zacksenhaus, Jeff C. Liu, Letizia Granieri, Ioulia Vorobieva, Dong-Yu Wang, Ronak Ghanbari-Azarnier, Huiqin Li, Amjad Ali, Philip E.D. Chung, YoungJun Ju, Zhe Jiang, Mariusz Shrestha

    Published 2018-07-01
    Get full text
    Article
  8. 8
    Combined deletion of Pten and p53 in mammary epithelium accelerates triple‐negative breast cancer with dependency on eEF2K

    Combined deletion of Pten and p53 in mammary epithelium accelerates triple‐negative breast cancer with dependency on eEF2K by Jeff C Liu, Veronique Voisin, Sharon Wang, Dong‐Yu Wang, Robert A Jones, Alessandro Datti, David Uehling, Rima Al‐awar, Sean E Egan, Gary D Bader, Ming Tsao, Tak W Mak, Eldad Zacksenhaus

    Published 2014-12-01
    Get full text
    Article
  9. 9
    Thinking (Metastasis) outside the (Primary Tumor) Box

    Thinking (Metastasis) outside the (Primary Tumor) Box by Zhe Jiang, Young-Jun Ju, Amjad Ali, Philip E. D. Chung, Dong-Yu Wang, Jeff C. Liu, Huiqin Li, Ioulia Vorobieva, Ethel Mwewa, Ronak Ghanbari-Azarnier, Mariusz Shrestha, Yaacov Ben-David, Eldad Zacksenhaus

    Published 2023-11-01
    Get full text
    Article
  10. 10
    Identification of CDC25 as a Common Therapeutic Target for Triple-Negative Breast Cancer

    Identification of CDC25 as a Common Therapeutic Target for Triple-Negative Breast Cancer by Jeff C. Liu, Letizia Granieri, Mariusz Shrestha, Dong-Yu Wang, Ioulia Vorobieva, Elizabeth A. Rubie, Rob Jones, YoungJun Ju, Giovanna Pellecchia, Zhe Jiang, Carlo A. Palmerini, Yaacov Ben-David, Sean E. Egan, James R. Woodgett, Gary D. Bader, Alessandro Datti, Eldad Zacksenhaus

    Published 2018-04-01
    Get full text
    Article
  11. 11
    Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapy

    Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapy by Philip E. D. Chung, Deena M. A. Gendoo, Ronak Ghanbari-Azarnier, Jeff C. Liu, Zhe Jiang, Jennifer Tsui, Dong-Yu Wang, Xiao Xiao, Bryan Li, Adrian Dubuc, David Shih, Marc Remke, Ben Ho, Livia Garzia, Yaacov Ben-David, Seok-Gu Kang, Sidney Croul, Benjamin Haibe-Kains, Annie Huang, Michael D. Taylor, Eldad Zacksenhaus

    Published 2020-04-01
    Get full text
    Article
  12. 12
    Distinct shared and compartment-enriched oncogenic networks drive primary versus metastatic breast cancer

    Distinct shared and compartment-enriched oncogenic networks drive primary versus metastatic breast cancer by Zhe Jiang, YoungJun Ju, Amjad Ali, Philip E. D. Chung, Patryk Skowron, Dong-Yu Wang, Mariusz Shrestha, Huiqin Li, Jeff C. Liu, Ioulia Vorobieva, Ronak Ghanbari-Azarnier, Ethel Mwewa, Marianne Koritzinsky, Yaacov Ben-David, James R. Woodgett, Charles M. Perou, Adam Dupuy, Gary D. Bader, Sean E. Egan, Michael D. Taylor, Eldad Zacksenhaus

    Published 2023-07-01
    Get full text
    Article

Search Tools: